214 related articles for article (PubMed ID: 19942610)
1. Functional identification of LRF as an oncogene that bypasses RASV12-induced senescence via upregulation of CYCLIN E.
Vredeveld LC; Rowland BD; Douma S; Bernards R; Peeper DS
Carcinogenesis; 2010 Feb; 31(2):201-7. PubMed ID: 19942610
[TBL] [Abstract][Full Text] [Related]
2. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence.
Peeper DS; Shvarts A; Brummelkamp T; Douma S; Koh EY; Daley GQ; Bernards R
Nat Cell Biol; 2002 Feb; 4(2):148-53. PubMed ID: 11812999
[TBL] [Abstract][Full Text] [Related]
3. A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling.
Shvarts A; Brummelkamp TR; Scheeren F; Koh E; Daley GQ; Spits H; Bernards R
Genes Dev; 2002 Mar; 16(6):681-6. PubMed ID: 11914273
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional factor HBP1 targets P16(INK4A), upregulating its expression and consequently is involved in Ras-induced premature senescence.
Li H; Wang W; Liu X; Paulson KE; Yee AS; Zhang X
Oncogene; 2010 Sep; 29(36):5083-94. PubMed ID: 20581871
[TBL] [Abstract][Full Text] [Related]
5. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene.
Davies JM; Hawe N; Kabarowski J; Huang QH; Zhu J; Brand NJ; Leprince D; Dhordain P; Cook M; Morriss-Kay G; Zelent A
Oncogene; 1999 Jan; 18(2):365-75. PubMed ID: 9927193
[TBL] [Abstract][Full Text] [Related]
6. The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins.
Deng Q; Li Y; Tedesco D; Liao R; Fuhrmann G; Sun P
Cancer Res; 2005 Sep; 65(18):8298-307. PubMed ID: 16166306
[TBL] [Abstract][Full Text] [Related]
7. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
Alevizopoulos K; Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992
[TBL] [Abstract][Full Text] [Related]
8. PPP1CA contributes to the senescence program induced by oncogenic Ras.
Castro ME; Ferrer I; Cascón A; Guijarro MV; Lleonart M; Ramón y Cajal S; Leal JF; Robledo M; Carnero A
Carcinogenesis; 2008 Mar; 29(3):491-9. PubMed ID: 18204081
[TBL] [Abstract][Full Text] [Related]
9. Escape from premature senescence is not sufficient for oncogenic transformation by Ras.
Peeper DS; Dannenberg JH; Douma S; te Riele H; Bernards R
Nat Cell Biol; 2001 Feb; 3(2):198-203. PubMed ID: 11175753
[TBL] [Abstract][Full Text] [Related]
10. Identification of a candidate tumor-suppressor gene specifically activated during Ras-induced senescence.
Barradas M; Gonos ES; Zebedee Z; Kolettas E; Petropoulou C; Delgado MD; León J; Hara E; Serrano M
Exp Cell Res; 2002 Feb; 273(2):127-37. PubMed ID: 11822868
[TBL] [Abstract][Full Text] [Related]
11. MyoD activity upregulates E2F1 and enhances transcription from the cyclin E promoter in differentiating myoblasts lacking a functional retinoblastoma protein.
Tedesco D; Vesco C
Exp Cell Res; 2001 Oct; 269(2):301-11. PubMed ID: 11570822
[TBL] [Abstract][Full Text] [Related]
12. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
[TBL] [Abstract][Full Text] [Related]
14. Ha-Ras(G12V) induces senescence in primary and immortalized human esophageal keratinocytes with p53 dysfunction.
Takaoka M; Harada H; Deramaudt TB; Oyama K; Andl CD; Johnstone CN; Rhoades B; Enders GH; Opitz OG; Nakagawa H
Oncogene; 2004 Sep; 23(40):6760-8. PubMed ID: 15273725
[TBL] [Abstract][Full Text] [Related]
15. C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence.
Sebastian T; Malik R; Thomas S; Sage J; Johnson PF
EMBO J; 2005 Sep; 24(18):3301-12. PubMed ID: 16107878
[TBL] [Abstract][Full Text] [Related]
16. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
Palmero I; Murga M; Zubiaga A; Serrano M
Oncogene; 2002 May; 21(19):2939-47. PubMed ID: 12082524
[TBL] [Abstract][Full Text] [Related]
17. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression.
Passegué E; Wagner EF
EMBO J; 2000 Jun; 19(12):2969-79. PubMed ID: 10856241
[TBL] [Abstract][Full Text] [Related]
18. K-ras modulates the cell cycle via both positive and negative regulatory pathways.
Fan J; Bertino JR
Oncogene; 1997 May; 14(21):2595-607. PubMed ID: 9191059
[TBL] [Abstract][Full Text] [Related]
19. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.
Sato M; Vaughan MB; Girard L; Peyton M; Lee W; Shames DS; Ramirez RD; Sunaga N; Gazdar AF; Shay JW; Minna JD
Cancer Res; 2006 Feb; 66(4):2116-28. PubMed ID: 16489012
[TBL] [Abstract][Full Text] [Related]
20. RhoE inhibits cell cycle progression and Ras-induced transformation.
Villalonga P; Guasch RM; Riento K; Ridley AJ
Mol Cell Biol; 2004 Sep; 24(18):7829-40. PubMed ID: 15340047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]